0001104659-23-089936.txt : 20230810 0001104659-23-089936.hdr.sgml : 20230810 20230810184837 ACCESSION NUMBER: 0001104659-23-089936 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230808 FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIBOWITZ LAWRENCE E CENTRAL INDEX KEY: 0001276505 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40949 FILM NUMBER: 231161062 MAIL ADDRESS: STREET 1: C/O NYSE EURONEXT STREET 2: 11 WALL STREET CITY: NEW YORK STATE: NY ZIP: 10005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enfusion, Inc. CENTRAL INDEX KEY: 0001868912 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 BUSINESS PHONE: (312) 253-9800 MAIL ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 4 1 tm2323475-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-08 0 0001868912 Enfusion, Inc. ENFN 0001276505 LEIBOWITZ LAWRENCE E C/O ENFUSION, INC. 125 SOUTH CLARK STREET SUITE 750 CHICAGO IL 60603 1 0 0 0 0 Class A Common Stock 2023-08-08 4 A 0 1733 0 A 141017 D Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan. /s/ Matthew Campobasso, as Attorney-in-Fact 2023-08-10